L. Robert Johnson is Director at WEST PHARMACEUTICAL SERVICES INC (WST). They have made 14 open-market trades across 1 company since 2006, most recently 2013-08-22.
CIK 0001205315
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 14 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| WST | 19,436 | $7.5M |
Shares reported on the most recent Form 4, priced at the 2013-08-23 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| WST | SELL | 2013-08-22 | 2013-08-23 | $76.81 | $145K | -5.9% | -2.8% | -2.8% |
| WST | SELL | 2013-05-24 | 2013-05-28 | $67.47 | $115K | -5.9% | -2.8% | -2.8% |
| WST | SELL | 2013-05-17 | 2013-05-17 | $67.80 | $271K | -5.9% | -2.8% | -2.8% |
| WST | SELL | 2013-05-08 | 2013-05-09 | $64.49 | $413K | -5.9% | -2.8% | -2.8% |
| WST | SELL | 2012-08-17 | 2012-08-21 | $48.10 | $154K | -5.9% | -2.8% | -2.8% |
| WST | SELL | 2012-08-14 | 2012-08-15 | $47.77 | $153K | -5.9% | -2.8% | -2.8% |
| WST | SELL | 2012-05-29 | 2012-05-30 | $47.81 | $111K | -5.9% | -2.8% | -2.8% |
| WST | SELL | 2012-02-28 | 2012-02-29 | $42.16 | $51K | -5.9% | -2.8% | -2.8% |
| WST | SELL | 2010-11-08 | 2010-11-10 | $39.18 | $39K | -5.9% | -2.8% | -2.8% |
| WST | SELL | 2010-11-05 | 2010-11-09 | $39.16 | $78K | -5.9% | -2.8% | -2.8% |
| WST | SELL | 2010-11-04 | 2010-11-08 | $39.13 | $39K | -5.9% | -2.8% | -2.8% |
| WST | SELL | 2008-08-15 | 2008-08-18 | $50.91 | $204K | -5.9% | -2.8% | -2.8% |
| WST | SELL | 2008-05-22 | 2008-05-22 | $47.06 | $118K | -5.9% | -2.8% | -2.8% |
| WST | SELL | 2006-08-29 | 2006-08-30 | $38.98 | $78K | -5.9% | -2.8% | -2.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.